Skip to main content
Article thumbnail
Location of Repository

Modulation of the virus-receptor interaction by mutations in the V5 loop of feline immunodeficiency virus (FIV) following in vivo escape from neutralising antibody

By Brian J. Willett, Martin Kraase, Nicola Logan, Elizabeth L. McMonagle, Ayman Samman and Margaret J. Hosie


<b>BACKGROUND:</b> In the acute phase of infection with feline immunodeficiency virus (FIV), the virus targets activated CD4+ T cells by utilising CD134 (OX40) as a primary attachment receptor and CXCR4 as a co-receptor. The nature of the virus-receptor interaction varies between isolates; strains such as GL8 and CPGammer recognise a "complex" determinant on CD134 formed by cysteine-rich domains (CRDs) 1 and 2 of the molecule while strains such as PPR and B2542 require a more "simple" determinant comprising CRD1 only for infection. These differences in receptor recognition manifest as variations in sensitivity to receptor antagonists. In this study, we ask whether the nature of the virus-receptor interaction evolves in vivo.<p></p>\ud <b>RESULTS:</b> Following infection with a homogeneous viral population derived from a pathogenic molecular clone, a quasispecies emerged comprising variants with distinct sensitivities to neutralising antibody and displaying evidence of conversion from a "complex" to a "simple" interaction with CD134. Escape from neutralising antibody was mediated primarily by length and sequence polymorphisms in the V5 region of Env, and these alterations in V5 modulated the virus-receptor interaction as indicated by altered sensitivities to antagonism by both anti-CD134 antibody and soluble CD134.<p></p>\ud <b>CONCLUSIONS:</b> The FIV-receptor interaction evolves under the selective pressure of the host humoral immune response, and the V5 loop contributes to the virus-receptor interaction. Our data are consistent with a model whereby viruses with distinct biological properties are present in early versus late infection and with a shift from a "complex" to a "simple" interaction with CD134 with time post-infection.<p></p&gt

Topics: QR355
Publisher: BioMed Central
Year: 2010
OAI identifier:
Provided by: Enlighten

Suggested articles


  1. (2004). BJ: Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science
  2. (1987). Calos MP: Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol
  3. (1999). Chemokine receptors as HIV-1 coreceptors:Roles in viral entry, tropism, and disease. Annual Review of Immunology doi
  4. (2008). Cheng-Mayer C: R5X4 viruses are evolutionary, functional, and antigenic intermediates in the pathway of a simianhuman immunodeficiency virus coreceptor switch. doi
  5. (1995). Clapham PR: Change in tropism upon immune escape by human immunodeficiency virus.
  6. (1995). Clapham PR: Immune escape and tropism of HIV. Trends Microbiol doi
  7. (1997). Clapham PR: Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses.
  8. (1992). Clinical and pathological findings in feline immunodeficiency virus experimental infection. Vet Immunol Immunopathol doi
  9. (1999). Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection.
  10. (1999). Coreceptor specificity of temporal variants of simian immunodeficiency virus Mne. J Virol
  11. (2001). During readaptation in vivo, a tissue culture-adapted strain of feline immunodeficiency virus reverts to broad neutralization resistance at different times in individual hosts but through changes at the same position of the surface glycoprotein. doi
  12. (1996). EA: CC CKR5: A RANTES, MIP-1a, MIP-1b receptor as a fusion cofactor for macrophage-tropic HIV-1. Science doi
  13. (1996). EA: HIV-1 entry co-factor: functional cDNA cloning of a seven-transmembrane, G proteincoupled receptor. Science doi
  14. (2006). Elder JH: Sequential CD134-CXCR4 interactions in feline immunodeficiency virus (FIV): soluble CD134 activates FIV Env for CXCR4-dependent entry and reveals a cryptic neutralization epitope. doi
  15. (2004). Elder JH: Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus. Nat Struct Mol Biol doi
  16. entry into CD4+ cells is mediated by the chemokine receptor CC-CKR5. Nature doi
  17. (2004). Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor. Proc Natl Acad Sci USA doi
  18. (2001). Feline immunodeficiency virus-infected cat sera associated with the development of broad neutralization resistance in vivo drive similar reversions in vitro. doi
  19. (2006). Fenyo EM: Comparative studies on mucosal and intravenous transmission of simian immunodeficiency virus (SIVsm): evolution of coreceptor use varies with pathogenic outcome. JGV doi
  20. (1997). Fenyo EM: Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype.
  21. (2000). Greenberg ML: Evolution of the human immunodeficiency virus type 1 envelope during infection reveals molecular corollaries of specificity for coreceptor utilization and AIDS pathogenesis. doi
  22. (2010). Gruffydd-Jones TJ: Number and ownership profiles of cats and dogs in the UK. Vet Rec doi
  23. (1999). Heveker N: Shared usage of the chemokine receptor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus.
  24. (1996). Histological classification and immunophenotype of lymphosarcomas in cats with naturally and experimentally acquired feline immunodeficiency virus infections. Vet Pathol doi
  25. (2003). HIV-1 coreceptor usage, transmission, and disease progression. doi
  26. (2008). Hosie MJ: A single site for N-linked glycosylation in the envelope glycoprotein of feline immunodeficiency virus modulates the virus-receptor interaction. Retrovirology doi
  27. (2008). Hosie MJ: Chemokine receptors and co-stimulatory molecules: Unravelling feline immunodeficiency virus infection. Vet Immunol Immunopathol doi
  28. (2006). Hosie MJ: Differential utilization of CD134 as a functional receptor by diverse strains of feline immunodeficiency virus (FIV). doi
  29. (2009). Hosie MJ: Enforced covalent trimerisation of soluble feline CD134 (OX40)-ligand generates a functional antagonist of feline immunodeficiency virus. Mol Immunol doi
  30. (2010). Hosie MJ: Feline immunodeficiency virus env gene evolution in experimentally infected cats. Vet Immunol Immunopathol doi
  31. (1997). Hosie MJ: FIV infection of the domestic cat: an animal model for AIDS. Immunol Today doi
  32. (2010). Hosie MJ: Neutralisation of feline immunodeficiency virus by antibodies targeting the V5 Loop of Env. doi
  33. (2002). Hosie MJ: Upregulation of surface feline CXCR4 expression following ectopic expression of CCR5: implications for studies of the cell tropism of feline immunodeficiency virus. doi
  34. (1997). Hoxie JA: Common mechanism of infection by lentiviruses. Nature doi
  35. (2004). Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies. doi
  36. (1987). JK: Isolation of a Tlymphotropic virus from domestic cats with an immunodeficiency syndrome. Science
  37. (1990). LE: A feline large granular lymphoma and its derived cell line. doi
  38. (1998). Looney DJ: CXCR4 requirement for a nonprimate lentivirus:heterologous expression of FIV in human, rodent and feline cells.
  39. (1997). Lusso P: In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokinemediated suppression. Nat Med doi
  40. (2006). Mapping the domains of CD134 as a functional receptor for feline immunodeficiency virus. doi
  41. (1990). MD: Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus.
  42. (1984). Montagnier L: T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature doi
  43. (1989). NC: Epidemiologic and clinical aspects of FIV infection in cats from the continental U.S. and Canada and possible mode of transmission.
  44. (1989). NC: Feline immunodeficiency virus is a lentivirus associated with an AIDSlike disease in cats. AIDS doi
  45. (1991). NC: Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus.
  46. (1996). NC: Proviral burden and infection kinetics of feline immunodeficiency virus in lymphocyte subsets of blood and lymph node.
  47. (1997). NR: Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. doi
  48. (1996). NR: Identification of a major co-receptor for primary isolates of HIV-1. Nature doi
  49. (1995). NR: Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology doi
  50. (2002). O: Evolution of replication efficiency following infection with a molecularly cloned feline immunodeficiency virus of low virulence. doi
  51. (1996). Osterhaus ADME: Neutralization of feline immunodeficiency virus by polyclonal feline antibody: simultaneous involvement of hypervariable regions 4 and 5 of the surface glycoprotein.
  52. (1989). Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus in cats in the United Kingdom. Vet Rec doi
  53. (2007). Probing the interaction between the feline immunodeficiency virus and CD134 using a novel monoclonal antibody 7D6 and CD134L (OX40L). J Virol doi
  54. (1993). Production of high-titer helper-free retroviruses by transient transfection. doi
  55. (1984). RA: The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature doi
  56. (2010). Received: 4
  57. (2004). Schuitemaker H: In vivo evolution of ×4 human immunodeficiency virus type 1 variants in the natural course of infection coincides with decreasing sensitivity to CXCR4 antagonists. doi
  58. (1993). Structure and variations of feline immunodeficiency virus envelope glycoproteins. Virology doi
  59. (2004). Suchard MA: Evolution of human immunodeficiency virus type 1 coreceptor usage during antiretroviral Therapy: a Bayesian approach. doi
  60. (2007). t Wout AB, Schuitemaker H: T cell line passage can select for pre-existing neutralization-sensitive variants from the quasispecies of primary human immunodeficiency virus type-1 isolates. Virology doi
  61. (1989). T: Establishment of a feline T-lymphoblastoid cell line highly sensitive for replication of feline immunodeficiency virus. Arch Virol doi
  62. (1998). The bicyclam AMD3100, a selective antagonist of the human chemokine receptor CXCR4, inhibits feline immunodeficiency virus (FIV) replication in vitro.
  63. The Felid Immunodeficiency Viruses: Viral Cell Tropism and the Pathogenesis of Feline AIDS.
  64. (1993). The feline immunodeficiency virus. doi
  65. (1986). The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell doi
  66. (1993). Tompkins MB: In vivo lymphocyte tropism of feline immunodeficiency virus.
  67. (1995). Tozzini F: Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin Microbiol Rev doi
  68. (2000). Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.